Dermatology Drugs Market [(By Therapeutic Area (Atopic Dermatitis, Psoriasis, Acne, Rosacea), By Marketed Therapies (Biologics, Oral Drugs, Topical Drugs), By Approved Treatments (etanercept (Enbrel), infliximab (Remicade), adalimumab (Humira), ustekinumab (Stelara), secukinumab (Cosentyx), ixekizumab (Taltz), golimumab (Simponi), brodalumab (Siliq), and guselkamab (Tremfya), and By Region]: Market Size & Forecast, 2017 – 2022
- Published Date: Feb 2018
- Pages: 75
- Format: PDF
- Report ID: PM1106
- Base Year: 2016
- 历史数据:2015 - 2016
Report Content
The Marketed Therapies undertaken in forecast from 2016-2022 are:
- etanercept; Enbrel
- infliximab; Remicade
- adalimumab; Humira
- ustekinumab; Stelara
- secukinumab; Cosentyx
- ixekizumab; Taltz
- golimumab; Simponi
- brodalumab; Siliq
- guselkamab; Tremfya
- Topical Drugs
- Oral Antibiotics
The Major Indications in Dermatology Drugs Market Therapy area:
- Atopic Dermatitis
- Psoriasis
- Acne
- Rosacea
Leading Companies investigated in the Report are
- Allergan Plc
- Valeant Pharmaceuticals
- Dermira Inc
- Aclaris Therapeutics, Inc
- AnaptysBio, Inc
- Revance Therapeutics
- Foamix Pharmaceuticals
- Novan, Inc
- Sienna Biopharmaceuticals
- Pfizer
- Sanofi
- Galderma
- Leo Pharma
- Roviant Sciences
- Otsuka Pharmaceuticals
License and Pricing
Purchase Report Sections
- Regional analysis
- Segmentation analysis
- Industry outlook
- Competitive landscape
Connect With Experts
Suggested Report
- Non-Invasive Prenatal Testing (NIPT) Market Share, Size, Trends, Industry Analysis Report, 2021 - 2028
- PET-CT Scanner Device Market Share, Size, Trends, Industry Analysis Report, 2021 - 2028
- Primary Cells Market Share, Size, Trends, Industry Analysis Report, 2021 - 2028
- 再分mal Contraceptive Implants Market Share, Size, Trends, Industry Analysis Report, 2021 - 2028
- Nuclear Medicine Market Share, Size, Trends, Industry Analysis Report, 2021 - 2028
Global Dermatology Drugs Market Size & Share - Industry Report, 2022